These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 20855724)

  • 1. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.
    Moffatt JH; Harper M; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2011 Jun; 55(6):3022-4. PubMed ID: 21402838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.
    Henry R; Vithanage N; Harrison P; Seemann T; Coutts S; Moffatt JH; Nation RL; Li J; Harper M; Adler B; Boyce JD
    Antimicrob Agents Chemother; 2012 Jan; 56(1):59-69. PubMed ID: 22024825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.
    García-Quintanilla M; Pulido MR; Moreno-Martínez P; Martín-Peña R; López-Rojas R; Pachón J; McConnell MJ
    Antimicrob Agents Chemother; 2014 May; 58(5):2972-5. PubMed ID: 24566189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii.
    Kang KN; Kazi MI; Biboy J; Gray J; Bovermann H; Ausman J; Boutte CC; Vollmer W; Boll JM
    mBio; 2021 Jan; 12(1):. PubMed ID: 33402533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
    Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
    J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
    El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin Resistance in
    Hua X; Liu L; Fang Y; Shi Q; Li X; Chen Q; Shi K; Jiang Y; Zhou H; Yu Y
    Front Cell Infect Microbiol; 2017; 7():45. PubMed ID: 28275586
    [No Abstract]   [Full Text] [Related]  

  • 14. An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.
    Oddo A; Thomsen TT; Kjelstrup S; Gorey C; Franzyk H; Frimodt-Møller N; Løbner-Olesen A; Hansen PR
    Antimicrob Agents Chemother; 2016 Jan; 60(1):592-9. PubMed ID: 26574005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
    Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
    Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Polymyxin Resistance.
    Moffatt JH; Harper M; Boyce JD
    Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PmrAB, the two-component system of
    Yamada N; Kamoshida G; Shiraishi T; Yamaguchi D; Matsuoka M; Yamauchi R; Kanda N; Kamioka R; Takemoto N; Morita Y; Fujimuro M; Yokota S-i; Yahiro K
    J Bacteriol; 2024 May; 206(5):e0043523. PubMed ID: 38661375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
    Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.